v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 981,329 $ 816 $ 2,169,798 $ 604 $ (1,189,889)
Beginning Balance, Shares at Dec. 31, 2023   81,632,496      
Purchase of common stock under ESPP 1,398 $ 1 1,397    
Purchase of common stock under ESPP, Shares   76,461      
Vesting of restricted common stock   $ 4 (4)    
Vesting of restricted common stock, Shares   420,579      
Stock-based compensation 29,281   29,281    
Exercise of common stock options 1,676 $ 2 1,674    
Exercise of common stock options, Shares   151,291      
Other comprehensive income (loss) (1,525)     (1,525)  
Net loss (98,669)       (98,669)
Ending Balance at Mar. 31, 2024 913,490 $ 823 2,202,146 (921) (1,288,558)
Ending Balance, Shares at Mar. 31, 2024   82,280,827      
Beginning Balance at Dec. 31, 2023 981,329 $ 816 2,169,798 604 (1,189,889)
Beginning Balance, Shares at Dec. 31, 2023   81,632,496      
Net loss (189,720)        
Ending Balance at Jun. 30, 2024 854,094 $ 824 2,233,989 (1,110) (1,379,609)
Ending Balance, Shares at Jun. 30, 2024   82,386,210      
Beginning Balance at Mar. 31, 2024 913,490 $ 823 2,202,146 (921) (1,288,558)
Beginning Balance, Shares at Mar. 31, 2024   82,280,827      
Vesting of restricted common stock   $ 1 (1)    
Vesting of restricted common stock, Shares   72,040      
Stock-based compensation 31,604   31,604    
Exercise of common stock options 240   240    
Exercise of common stock options, Shares   33,343      
Other comprehensive income (loss) (189)     (189)  
Net loss (91,051)       (91,051)
Ending Balance at Jun. 30, 2024 854,094 $ 824 2,233,989 (1,110) (1,379,609)
Ending Balance, Shares at Jun. 30, 2024   82,386,210      
Beginning Balance at Dec. 31, 2024 733,545 $ 836 2,298,661 679 (1,566,631)
Beginning Balance, Shares at Dec. 31, 2024   83,633,069      
Purchase of common stock under ESPP 1,501 $ 1 1,500    
Purchase of common stock under ESPP, Shares   90,436      
Issuance of common stock and pre-funded warrants, net of issuance costs 470,478 $ 162 470,316    
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares   16,151,686      
Vesting of restricted common stock   $ 6 (6)    
Vesting of restricted common stock, Shares   607,196      
Stock-based compensation 26,682   26,682    
Exercise of common stock options 719 $ 1 718    
Exercise of common stock options, Shares   74,707      
Other comprehensive income (loss) (519)     (519)  
Net loss (109,270)       (109,270)
Ending Balance at Mar. 31, 2025 1,123,136 $ 1,006 2,797,871 160 (1,675,901)
Ending Balance, Shares at Mar. 31, 2025   100,557,094      
Beginning Balance at Dec. 31, 2024 $ 733,545 $ 836 2,298,661 679 (1,566,631)
Beginning Balance, Shares at Dec. 31, 2024   83,633,069      
Exercise of common stock options, Shares 195,198        
Net loss $ (211,561)        
Ending Balance at Jun. 30, 2025 1,046,813 $ 1,008 2,823,987 10 (1,778,192)
Ending Balance, Shares at Jun. 30, 2025   100,758,748      
Beginning Balance at Mar. 31, 2025 1,123,136 $ 1,006 2,797,871 160 (1,675,901)
Beginning Balance, Shares at Mar. 31, 2025   100,557,094      
Issuance of common stock and pre-funded warrants, net of issuance costs (4)   (4)    
Vesting of restricted common stock   $ 1 (1)    
Vesting of restricted common stock, Shares   81,163      
Stock-based compensation 24,367   24,367    
Exercise of common stock options 1,755 $ 1 1,754    
Exercise of common stock options, Shares   120,491      
Other comprehensive income (loss) (150)     (150)  
Net loss (102,291)       (102,291)
Ending Balance at Jun. 30, 2025 $ 1,046,813 $ 1,008 $ 2,823,987 $ 10 $ (1,778,192)
Ending Balance, Shares at Jun. 30, 2025   100,758,748